EUVIMEDScopri EUVIMED
Video/Audio

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Tommaso Sconocchia, Johannes Foßelteder, Thomas Köhnke, Ravindra Majeti, Andreas Reinisch

Journal of Visualized Experiments · 2023

DOI: 10.3791/64558 ↗

At a glance

Video/Audio in Journal of Visualized Experiments, 2023. Written by Tommaso Sconocchia and 4 co-authors. Institution: Division of Hematology, Department of Internal Medicine, Medical University of Graz. Major MEDLINE topics: Gain of Function Mutation, Gene Editing. Cited 3 times so far (Crossref); 50 references. Funded by: Austrian Science Fund FWF.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Throughout their lifetime, hematopoietic stem and progenitor cells (HSPCs) acquire somatic mutations. Some of these mutations alter HSPC functional properties such as proliferation and differentiation, thereby promoting the development of hematologic malignancies. Efficient and precise genetic manipulation of HSPCs is required to model, characterize, and better understand the functional consequences of recurrent somatic mutations. Mutations can have a deleterious effect on a gene and result in loss-of-function (LOF) or, in stark contrast, may enhance function or even lead to novel characteristics of a particular gene, termed gain-of-function (GOF). In contrast to LOF mutations, GOF mutations almost exclusively occur in a heterozygous fashion. Current genome-editing protocols do not allow for the selective targeting of individual alleles, hampering the ability to model heterozygous GOF mutations. Here, we provide a detailed protocol on how to engineer heterozygous GOF hotspot mutations in human HSPCs by combining CRISPR/Cas9-mediated homology-directed repair and recombinant AAV6 technology for efficient DNA donor template transfer. Importantly, this strategy makes use of a dual fluorescent reporter system to allow for the tracking and purification of successfully heterozygously edited HSPCs. This strategy can be employed to precisely investigate how GOF mutations affect HSPC function and their progression toward hematological malignancies.

Subjects

MeSH terms (MEDLINE)

Gain of Function MutationGene EditingHumansHematopoietic Stem CellsMutationCRISPR-Cas Systems

Authors and institutions

  • Division of Hematology, Department of Internal Medicine, Medical University of Graz.
  • Division of Hematology, Stanford Cancer Institute, Stanford Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine.
  • Division of Hematology, Department of Internal Medicine, Medical University of Graz; Department of Blood Group Serology and Transfusion Medicine, Medical University of Graz; a.reinisch@medunigraz.at.

Funding

  • Austrian Science Fund FWF

Cite

APA

Sconocchia, T., Foßelteder, J., Köhnke, T., Majeti, R., & Reinisch, A. (2023). Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells. Journal of Visualized Experiments. https://doi.org/10.3791/64558

Vancouver

Sconocchia T, Foßelteder J, Köhnke T, Majeti R, Reinisch A. Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells. Journal of Visualized Experiments. 2023. doi:10.3791/64558

BibTeX
@article{Sconocchia2023,
  author = {Sconocchia, Tommaso and Foßelteder, Johannes and Köhnke, Thomas and Majeti, Ravindra and Reinisch, Andreas},
  title = {Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells},
  journal = {Journal of Visualized Experiments},
  year = {2023},
  doi = {10.3791/64558}
}
Start for free →